In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how growing financial and logistical ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

The platform's patient-focused outreach is beneficial in navigating the complexities of evolving eligibility criteria for ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD - - Broadens global development program for vereki ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

During Neuralink’s summer update on the trial, they showed the moment one participant was able to move a cursor with his ...

PulseSight Therapeutics has announced that the first patient has been dosed in its phase 1 clinical trial evaluating PST-611, ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

The goal is to test whether the chip can give people who are paralyzed the ability to use their mind to control electronic devices.